Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Furst

Showing results (331-340 of 477) with videos related to

Pageof 48
Sort By:
Nursing Reports (Pavia, Italy)|March 27, 2024
The Rising Challenge of Poor Health Literacy of Patients with Systemic Sclerosis: Preliminary Data Identify Important Unmet Needs in an Italian CohortKhadija El Aoufy, Maria Ramona Melis, Paolo Iovino, et al.
Annals of the Rheumatic Diseases|May 18, 2010
Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT groupJérôme Avouac, Otylia Kowal-Bielecka, David Pittrow, et al.
Annals of the Rheumatic Diseases|September 16, 2020
Machine learning predicts stem cell transplant response in severe sclerodermaJennifer M Franks, Viktor Martyanov, Yue Wang, et al.
The Journal of Rheumatology|October 17, 2016
Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working GroupLouise Klokker, Peter Tugwell, Daniel E Furst, et al.
Arthritis Research & Therapy|June 25, 2011
Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are neededChristopher P Denton, Jerome Avouac, Frank Behrens, et al.
Plos One|January 17, 2008
Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?Jo N Fleming, Richard A Nash, D O McLeod, et al.
Rheumatology and Therapy|January 5, 2024
Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 YearsChristina Charles-Schoeman, Jon T Giles, Nancy E Lane, et al.
Arthritis Care & Research|February 7, 2018
Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort StudyRina S Fox, Linda Kwakkenbos, Marie-Eve Carrier, et al.
The Journal of Rheumatology|October 6, 2005
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module updateMarissa N D Lassere, Kent R Johnson, Maarten Boers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Association of Systemic Sclerosis With a Unique Colonic Microbial ConsortiumElizabeth R Volkmann, Yu-Ling Chang, Nashla Barroso, et al.
Pageof 48

Showing results (331-340 of 477) with videos related to

Sort By:
Pageof 48
Nursing Reports (Pavia, Italy)|March 27, 2024
The Rising Challenge of Poor Health Literacy of Patients with Systemic Sclerosis: Preliminary Data Identify Important Unmet Needs in an Italian CohortKhadija El Aoufy, Maria Ramona Melis, Paolo Iovino, et al.
Annals of the Rheumatic Diseases|May 18, 2010
Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT groupJérôme Avouac, Otylia Kowal-Bielecka, David Pittrow, et al.
Annals of the Rheumatic Diseases|September 16, 2020
Machine learning predicts stem cell transplant response in severe sclerodermaJennifer M Franks, Viktor Martyanov, Yue Wang, et al.
The Journal of Rheumatology|October 17, 2016
Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working GroupLouise Klokker, Peter Tugwell, Daniel E Furst, et al.
Arthritis Research & Therapy|June 25, 2011
Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are neededChristopher P Denton, Jerome Avouac, Frank Behrens, et al.
Plos One|January 17, 2008
Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?Jo N Fleming, Richard A Nash, D O McLeod, et al.
Rheumatology and Therapy|January 5, 2024
Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 YearsChristina Charles-Schoeman, Jon T Giles, Nancy E Lane, et al.
Arthritis Care & Research|February 7, 2018
Reliability and Validity of Three Versions of the Brief Fear of Negative Evaluation Scale in Patients With Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort StudyRina S Fox, Linda Kwakkenbos, Marie-Eve Carrier, et al.
The Journal of Rheumatology|October 6, 2005
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module updateMarissa N D Lassere, Kent R Johnson, Maarten Boers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Association of Systemic Sclerosis With a Unique Colonic Microbial ConsortiumElizabeth R Volkmann, Yu-Ling Chang, Nashla Barroso, et al.
Pageof 48